Evidence map›Paper›PMID 39564926›Full record

ArticleJournal of chemical information and modeling2024

Exploring the Potential of Adaptive, Local Machine Learning in Comparison to the Prediction Performance of Global Models: A Case Study from Bayer's Caco-2 Permeability Database.

Frank Filip Steinbauer, Thorsten Lehr, Andreas Reichel

Abstract readComparative Study
In one paragraph

Article in Journal of chemical information and modeling, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Frank Filip SteinbauerPreclinical Modeling and Simulation, Preclinical Development, Bayer AG, Muellerstr. 178, 13353 Berlin, Germany.ORCID 0009-0000-0539-3171
Thorsten LehrDepartment of Clinical Pharmacy, Saarland University, 66123 Saarbruecken, Germany.
Andreas ReichelPreclinical Modeling and Simulation, Preclinical Development, Bayer AG, Muellerstr. 178, 13353 Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Machine learning (ML) techniques are being widely implemented to fill the gap in simple molecular design guidelines for newer therapeutic modalities in the extended and beyond rule of five chemical space (eRo5, bRo5). These ML techniques predict molecular properties directly from the structure, allowing for the prioritization of promising compounds. However, the performance of models varies greatly among ML use cases. A molecular property for which achieving sufficient performance in generalizing global models still remains difficult is Caco-2 permeability. Especially within the lower permeability ranges, which are specific for larger molecules belonging to the e/bRo5 space, accurate regression predictions have proven to be challenging. The present study, therefore, identifies a suitable combination of ML algorithm and descriptors, consisting of the LightGBM algorithm and RDKit molecular property descriptors, to predict Caco-2 permeability very efficiently by a simple global model. An additionally introduced local model uses the same algorithm and descriptors but selects its training data based on Tanimoto fingerprint similarity to match the individual test compound's structure. Evaluation of this adaptive model, by systematically varying the number of most similar structures for training, shows that, in comparison to the global model, there was only marginally improved performance with specific training data constellations. These random improvements indicate that deriving general rules for local model parametrization is not possible

Indexed as

Machine LearningPermeabilityAlgorithmsCaco-2 CellsDatabases, FactualHumans

Identifiers

PMID39564926
PMCPMC11683871

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.